The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)

Published:2015-04-16 Issue:5 Volume:30 Page:934-944
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Black Dennis M.¹,Reid Ian R.²,Cauley Jane A.³,Cosman Felicia⁴,Leung Ping Chung⁵,Lakatos Peter⁶,Lippuner Kurt⁷,Cummings Steven R.⁸,Hue Trisha F.¹,Mukhopadhyay Amitava⁹,Tan Monique¹⁰,Aftring R. Paul¹⁰,Eastell Richard¹¹

Affiliation:

1. University of CaliforniaSan FranciscoCAUSA

2. University of AucklandAucklandNew Zealand

3. University of Pittsburgh Graduate School of Public HealthPittsburghPAUSA

4. Helen Hayes HospitalNew YorkNYUSA

5. Chinese University of Hong KongHong KongChina

6. Semmelweis University Medical SchoolBudapestHungary

7. Bern University HospitalBernSwitzerland

8. San Francisco Coordinating CenterSan FranciscoCAUSA

9. Novartis Healthcare Pvt. Ltd.HyderabadIndia

10. Novartis Pharmaceutical CorporationEast HanoverNJUSA

11. University of SheffieldSheffieldUK

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.2442

Reference15 articles.

1. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

2. Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial

3. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

4. Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis

5. Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal OsteoporosisA Randomized Controlled Trial

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sample size variation in single-time post-dose assessment vs multi-time post-dose assessment;F1000Research;2024-09-05

2. Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024;Journal of Bone and Mineral Research;2024-07-29

3. Deprescribing bisphosphonates in the osteoporosis treatment in older people;Osteoporosis and Bone Diseases;2024-04-17

4. Long-term therapy with bisphosphonates: review of clinical studies;Osteoporosis and Bone Diseases;2024-04-17

5. Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years;The Lancet Diabetes & Endocrinology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3